z-logo
open-access-imgOpen Access
Octreotide modified PEGylated liposomes improved the anticancer efficacy of doxorubicin in somatostatin receptor II positive tumor model
Author(s) -
Jun-Lin Zhang,
Qiang Zhang
Publication year - 2010
Publication title -
journal of chinese pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 12
ISSN - 1003-1057
DOI - 10.5246/jcps.2010.05.050
Subject(s) - somatostatin receptor , liposome , doxorubicin , octreotide , pharmacology , chemistry , somatostatin receptor 2 , somatostatin , cancer research , medicine , chemotherapy , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom